Quality Growth Management’s Gilead Sciences GILD Stock Holding History

Quality Growth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$299K	Buy	+2,550	New	+$279K	0.31%	17

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quality Growth Management's GILD Position: Q2 2015 in Review

Quality Growth Management opened a new position in Gilead Sciences (GILD) in Q2 2015: 2,550 shares worth $299K. The stake represents 0.31% of the portfolio and ranks #17 among its holdings.

1,559 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

Quality Growth Management held 2,550 shares of Gilead Sciences worth $299K as of Q2 2015.
Gilead Sciences was a new Quality Growth Management position in Q2 2015.
Gilead Sciences made up 0.31% of Quality Growth Management's portfolio in Q2 2015, its #17 holding.
1,559 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Quality Growth Management's 13F filing for Q2 2015, filed 12 Aug 2015.